Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of IRD will decline by -31.60% over the next 2 Weeks and hit $2.29 by Monday, August 10, 2026. In that time frame, IRD's share price is expected to range between $2.09 and $2.47.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 10, 2026 | 2.09 | 2.29 | 2.47 |
| Aug 7, 2026 | 2.23 | 2.41 | 2.58 |
| Aug 6, 2026 | 2.27 | 2.46 | 2.64 |
| Aug 5, 2026 | 2.38 | 2.54 | 2.71 |
| Aug 4, 2026 | 2.46 | 2.63 | 2.80 |
| Aug 3, 2026 | 2.56 | 2.72 | 2.89 |
| Jul 31, 2026 | 2.68 | 2.84 | 3.01 |
| Jul 30, 2026 | 2.73 | 2.89 | 3.05 |
| Jul 29, 2026 | 2.81 | 2.98 | 3.14 |
| Jul 28, 2026 | 2.90 | 3.07 | 3.23 |
IRD shares rose +1.79% in Tuesday, July 28, 2026's trading session, rising from a previous close of $3.35 to move at $3.41. The stock demonstrated notable intraday movement (see IRD's key stats for a full breakdown), fluctuating between $3.23 and $3.50, a +8.20% trading range. While recent weeks have seen some volatility, IRD has managed to secure a -4.21% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 538.57K shares changing hands, 550.64K fewer than the previous session. This amounted to $1.84M in total market activity.
Will IRD Continue Its Downward Trend?
According to analyst ratings and projections for IRD, Opus Genetics, Inc. shares are anticipated to decrease by -38.03%, potentially reaching $2.47 per share by August 10, 2026. Short-term technical indicators for IRD currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 16 negative trading days within the past 30 sessions. Based on the IRD stock forecast, now is not the best time to buy IRD stock because its current trading price is +48.82% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on IRD covering social and institutional perspectives.
IRD Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into IRD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 42.39% to 48.69%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.93%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.67%, maintains a neutral outlook for the long term. Insights into IRD's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Opus Genetics Short-Term Forecasts
IRD Forecast For Next 5 Days
Our algorithm anticipates Opus Genetics (IRD) stock could hit $3.35 by Aug 04, 2026. This represents a -1.63% rise from today's price, following a +10.24% change over the past five days.
IRD Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Opus Genetics, Inc. (IRD) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.00, which would mean a -12.02% decrease from the current price of $3.41. Projections for this period range from a high of $3.80 to a low of $2.18.
IRD Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Opus Genetics's price over the next three months point to a rise. IRD stock is expected to peak at $36.52 on Oct 07, 2026 after potentially dipping to $16.00 on Jul 28, 2026. On average, IRD is likely to trade around $28.78 in the coming 90 days.
Opus Genetics Stock Forecast 2025
Based on our predictive models, Opus Genetics (IRD) is expected to trade between $16.00 and $36.52 throughout 2026. This would result in an average price of $27.18, potentially offering investors a +697.07% return from current levels.
Opus Genetics, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Opus Genetics, Inc. (IRD) is positioned to show a strong performance in July 2026. The price is predicted to move between $16.00 and $19.12, settling at an average of $17.54. This could translate to a +414.37% gain.
August 2026
Based on current market signals, Opus Genetics, Inc. is projected to trend august 2026. We forecast a trading range from $21.64 to $24.35, with a likely average price of $22.87. Investors could expect a potential return of +570.67%.
September 2026
Our predictive algorithms indicate Opus Genetics, Inc. stock may see a shift in September 2026. The expected range spans $24.87–$34.75, with an average target of $31.89. This represents a positive outlook and a possible gain of +835.19%.
October 2026
Analyzing established trends, Opus Genetics, Inc. looks set to move in October 2026. Projections place the stock between $29.32 and $36.52, averaging around $33.42. This suggests a +880.06% gain from current levels.
November 2026
Market indicators suggest Opus Genetics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $25.73 to $27.98, with a midpoint forecast of $27.06. The stock might deliver a +693.55% gain.
December 2026
Forecasting for December 2026, models estimate that Opus Genetics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $18.29 and $26.89, averaging $22.41. This signals a positive trajectory with potential returns around +557.18%.
January 2027
According to our latest forecast models, Opus Genetics, Inc. (IRD) is positioned to show a strong performance in January 2027. The price is predicted to move between $21.84 and $25.96, settling at an average of $23.92. This could translate to a +601.47% gain.
February 2027
Based on current market signals, Opus Genetics, Inc. is projected to trend february 2027. We forecast a trading range from $27.90 to $32.91, with a likely average price of $30.73. Investors could expect a potential return of +801.17%.
March 2027
Our predictive algorithms indicate Opus Genetics, Inc. stock may see a shift in March 2027. The expected range spans $21.17–$32.88, with an average target of $28.04. This represents a positive outlook and a possible gain of +722.29%.
April 2027
Analyzing established trends, Opus Genetics, Inc. looks set to move in April 2027. Projections place the stock between $20.37 and $25.78, averaging around $23.23. This suggests a +581.23% gain from current levels.
May 2027
Market indicators suggest Opus Genetics, Inc. could experience notable changes during May 2027. Prices could fluctuate within $13.84 to $22.43, with a midpoint forecast of $17.59. The stock might deliver a +415.84% gain.
June 2027
Forecasting for June 2027, models estimate that Opus Genetics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $17.61 and $23.52, averaging $20.24. This signals a positive trajectory with potential returns around +493.55%.
July 2027
According to our latest forecast models, Opus Genetics, Inc. (IRD) is positioned to show a strong performance in July 2027. The price is predicted to move between $18.38 and $26.01, settling at an average of $22.44. This could translate to a +558.06% gain.
IRD's history of dividends and stock splits also plays a role in long-term investor confidence.

